Comments
Transcript
by Barbara Botto, Alessia Castellino, Annalisa
De-Novo Diffuse Large B Cell Lymphoma (DLBCL) Treated with Rituximab (R)-CHOP: Definition and Validation of a Prognostic Score Model Based on MYC, BCL2 and BCL6 Expression By Immunohistochemistry (IHC) by Barbara Botto, Alessia Castellino, Annalisa Chiappella, Mattia Novo, Luigi Zattera, Federica Cavallo, Paola Ghione, Andrea Evangelista, Chiara Ciochetto, Giovannino Ciccone, Maria Stella Scalzo, Roberto Chiarle, Domenico Novero, and Umberto Vitolo Blood Volume 126(23):2650-2650 December 3, 2015 ©2015 by American Society of Hematology 5-yrs PFS in 153 patients (Validation cohort + Study cohort). Barbara Botto et al. Blood 2015;126:2650 ©2015 by American Society of Hematology 5-yrs OS in 153 patients (Validation cohort + Study cohort). Barbara Botto et al. Blood 2015;126:2650 ©2015 by American Society of Hematology